Income Statement Colinz Laboratories Limited

Stocks

COLINZ6

INE923C01011

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 02:08:16 2026-07-24 EDT			5-day change	1st Jan Change
79.90 ^INR	-0.73%		+2.38%	+48.98%

06-17	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million,	CI
06-17	Annjana Dugar, Likhitta Dugar and Antariksh Dugar proposed to acquire an additional 26% stake in Colinz Laboratories Limited for INR 35.4 million.	CI

33bde.5GKt1O2ZDlpNZ5LHSetak942qtaWvWqx8ljx2wjJXR8.k1XgoNmoSSM_Et31EJkXvrAF34zZ7gXopXXC63DkDVGHNMaVi-g7DyoD0w

Published financial data: COLINZ LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	61.59M	69.74M	71.55M	70.3M	65.28M
Total Revenues	61.59M	69.74M	71.55M	70.3M	65.28M
Cost of Goods Sold, Total	22.29M	23.74M	23.94M	24.46M	21.41M
Gross Profit	39.3M	46.01M	47.61M	45.84M	43.87M
Selling General & Admin Expenses, Total	26.79M	30.34M	32M	31.34M	30.27M
Depreciation & Amortization - (IS)	1.91M	2.01M	1.29M	1.3M	1.31M
Other Operating Expenses	9.18M	9.8M	9.28M	9.08M	8.65M
Other Operating Expenses, Total	37.88M	42.16M	42.57M	41.72M	40.23M
Operating Income	1.42M	3.85M	5.04M	4.12M	3.64M
Interest Expense, Total	-865K	-755K	-523K	-372K	-424K
Interest And Investment Income	1.7M	1.67M	1.7M	2.74M	2.88M
Net Interest Expenses	830K	916K	1.18M	2.37M	2.46M
Other Non Operating Income (Expenses)	203K	37K	20K	12K	100K
EBT, Excl. Unusual Items	2.45M	4.8M	6.24M	6.5M	6.19M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-237K	-	-
EBT, Incl. Unusual Items	2.45M	4.8M	6M	6.5M	6.19M
Income Tax Expense	376K	1.41M	1.42M	1.64M	1.23M
Earnings From Continuing Operations	2.08M	3.39M	4.57M	4.87M	4.97M
Net Income to Company	2.08M	3.39M	4.57M	4.87M	4.97M
Net Income - (IS)	2.08M	3.39M	4.57M	4.87M	4.97M
Net Income to Common Incl Extra Items	2.08M	3.39M	4.57M	4.87M	4.97M
Net Income to Common Excl. Extra Items	2.08M	3.39M	4.57M	4.87M	4.97M
Per Share Items
Net EPS - Basic	0.45	0.74	1.82	1.93	1.97
Basic EPS - Continuing Operations	0.45	0.74	1.82	1.93	1.97
Basic Weighted Average Shares Outstanding	4.57M	4.59M	2.51M	2.52M	2.52M
Net EPS - Diluted	0.45	0.74	1.82	1.93	1.97
Diluted EPS - Continuing Operations	0.45	0.74	1.82	1.93	1.97
Diluted Weighted Average Shares Outstanding	4.57M	4.59M	2.51M	2.52M	2.52M
Normalized Basic EPS	0.34	0.65	1.55	1.61	1.54
Normalized Diluted EPS	0.34	0.65	1.55	1.61	1.54
Supplemental Items
EBITDA	3.33M	5.86M	6.33M	5.43M	4.95M
EBITA	1.42M	3.85M	5.04M	4.12M	3.64M
EBIT	1.42M	3.85M	5.04M	4.12M	3.64M
EBITDAR	4.96M	7.06M	7.83M	7.15M	6.66M
Total Revenues (As Reported)	63.5M	71.45M	73.27M	73.05M	68.26M
Effective Tax Rate - (Ratio)	15.34	29.36	23.74	25.16	19.83
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	830K	1.44M	1.58M	1.78M	1.75M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-397K	-97K	-156K	-124K	-522K
Normalized Net Income	1.53M	3M	3.9M	4.06M	3.87M
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	1.7M	471K	293K	165K	433K
Supplemental Operating Expense Items
Advertising Expense	62.21K	114K	157K	111K	178K
Selling and Marketing Expenses	62.21K	114K	157K	111K	178K
Research And Development Expense From Footnotes	154K	62K	58K	82K	109K
Net Rental Expense, Total	1.63M	1.2M	1.5M	1.72M	1.71M
Imputed Operating Lease Interest Expense	1.65M	981K	1.66M	1.21M	960K
Imputed Operating Lease Depreciation	-12.78K	219K	-156K	506K	753K
Maintenance & Repair Expenses, Total	454K	750K	1.01M	1.32M	504K

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	13.95M	20.88M	19.65M	29.47M	24M
Short Term Investments	32.87M	31.18M	37.63M	40.54M	31.5M
Total Cash And Short Term Investments	46.81M	52.06M	57.29M	70M	55.5M
Accounts Receivable, Total	12.98M	12.06M	11.34M	8.59M	6.61M
Other Receivables	-	-	-	-	-
Total Receivables	12.98M	12.06M	11.34M	8.59M	6.61M
Inventory	12.47M	9.25M	9.39M	8.47M	7.81M
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	359K	416K	336K	290K	20.24M
Total Current Assets	72.62M	73.79M	78.35M	87.35M	90.16M
Gross Property Plant And Equipment	68.76M	69.13M	61.74M	61.74M	64.32M
Accumulated Depreciation	-48.5M	-50.52M	-44.65M	-45.95M	-47.31M
Net Property Plant And Equipment	20.26M	18.62M	17.09M	15.79M	17M
Long-term Investments	6.06M	6.69M	6.63M	10.22M	10.44M
Loans Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	1.96M	213K	234K	235K	560K
Total Assets	101M	99.31M	102M	114M	118M
Liabilities
Accounts Payable, Total	5.44M	4.75M	6.54M	5.98M	5.43M
Accrued Expenses, Total	7.88M	9.43M	8.99M	9.73M	9.37M
Short-term Borrowings	9.93M	4.84M	2.73M	5.7M	6.41M
Current Income Taxes Payable	-	17K	24K	-	-
Other Current Liabilities	2.48M	775K	571K	415K	415K
Total Current Liabilities	25.73M	19.82M	18.86M	21.82M	21.62M
Long-Term Debt	-	-	-	-	-
Deferred Tax Liability Non Current	2.25M	2.22M	2.06M	2.29M	1.81M
Other Non Current Liabilities	-	407K	-	-	-
Total Liabilities	27.98M	22.44M	20.92M	24.1M	23.43M
Common Stock, Total	35.45M	35.45M	25.19M	25.19M	25.19M
Additional Paid In Capital	15.23M	15.23M	10.1M	10.1M	10.1M
Retained Earnings	16.73M	20.13M	24.7M	29.57M	34.53M
Comprehensive Income and Other	5.5M	6.07M	21.4M	24.63M	24.92M
Total Common Equity	72.91M	76.87M	81.39M	89.49M	94.74M
Total Equity	72.91M	76.87M	81.39M	89.49M	94.74M
Total Liabilities And Equity	101M	99.31M	102M	114M	118M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.57M	4.57M	2.52M	2.52M	2.52M
ECS Total Common Shares Outstanding	4.57M	4.57M	2.52M	2.52M	2.52M
Book Value / Share	15.95	16.82	32.31	35.52	37.61
Tangible Book Value	72.91M	76.87M	81.39M	89.49M	94.74M
Tangible Book Value Per Share	15.95	16.82	32.31	35.52	37.61
Total Debt	9.93M	4.84M	2.73M	5.7M	6.41M
Net Debt	-36.89M	-47.22M	-54.55M	-64.3M	-49.09M
Debt Equivalent Oper. Leases	13.07M	9.6M	12M	13.76M	13.7M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.2M	1.27M	1.07M	963K	1.12M
Inventories - Finished Goods, Total	11.26M	7.98M	8.32M	7.51M	6.69M
Land - (BS)	2.57M	2.57M	2.57M	2.57M	2.57M
Buildings, Total	30.61M	30.61M	30.61M	30.61M	30.61M
Machinery, Total	35.58M	35.95M	28.56M	28.56M	31.14M
Full Time Employees	60	64	67	69	65

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	2.08M	3.39M	4.57M	4.87M	4.97M
Depreciation & Amortization - CF	1.91M	2.01M	1.29M	1.3M	1.31M
Depreciation & Amortization, Total	1.91M	2.01M	1.29M	1.3M	1.31M
(Gain) Loss From Sale Of Asset	-	-	237K	-	-
Other Operating Activities, Total	-1.22M	-1.05M	-1.35M	-2.49M	-3.31M
Change In Accounts Receivable	1.94M	918K	719K	2.75M	1.98M
Change In Inventories	4.45M	3.21M	-135K	919K	660K
Change In Accounts Payable	1.75M	-690K	1.79M	-568K	-545K
Change in Other Net Operating Assets	10.68M	-3.12M	-3.09M	3.57M	-19.6M
Cash from Operations	21.58M	4.67M	4.03M	10.35M	-14.54M
Capital Expenditure	-1.58M	-375K	-	-	-2.62M
Investment in Marketable and Equity Securities, Total	14.25K	-	-	-	192K
Other Investing Activities, Total	16.92K	50K	87K	69K	84K
Cash from Investing	-1.55M	-325K	87K	69K	-2.34M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	-	-	-	-	-
Other Financing Activities, Total	801K	903K	1.11M	2.3M	2.38M
Cash from Financing	801K	903K	1.11M	2.3M	2.38M
Net Change in Cash	20.84M	5.25M	5.23M	12.71M	-14.5M
Supplemental Items
Cash Interest Paid	865K	755K	523K	372K	424K
Cash Income Tax Paid (Refund)	773K	1.51M	1.58M	1.76M	2.08M
Levered Free Cash Flow	10.87M	6.81M	5.93M	7.35M	-17.51M
Unlevered Free Cash Flow	11.41M	7.28M	6.26M	7.59M	-17.25M
Change In Net Working Capital	-10.19M	-3.24M	-1.82M	-3.7M	18.21M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.94	2.4	3.12	2.39	1.96
Return on Total Capital	1.14	2.92	3.8	2.88	2.32
Return On Equity %	2.94	4.53	5.78	5.7	5.39
Return on Common Equity	2.94	4.53	5.78	5.7	5.39
Margin Analysis
Gross Profit Margin %	63.8	65.97	66.54	65.21	67.21
SG&A Margin	43.5	43.51	44.72	44.58	46.38
EBITDA Margin %	5.41	8.41	8.84	7.72	7.58
EBITA Margin %	2.3	5.52	7.04	5.87	5.57
EBIT Margin %	2.3	5.52	7.04	5.87	5.57
Income From Continuing Operations Margin %	3.37	4.86	6.39	6.92	7.61
Net Income Margin %	3.37	4.86	6.39	6.92	7.61
Net Avail. For Common Margin %	3.37	4.86	6.39	6.92	7.61
Normalized Net Income Margin	2.49	4.3	5.45	5.78	5.93
Levered Free Cash Flow Margin	17.65	9.77	8.29	10.46	-26.83
Unlevered Free Cash Flow Margin	18.52	10.44	8.75	10.79	-26.42
Asset Turnover
Asset Turnover	0.65	0.7	0.71	0.65	0.56
Fixed Assets Turnover	3.02	3.59	4.01	4.28	3.98
Receivables Turnover (Average Receivables)	4.42	5.57	6.12	7.05	8.59
Inventory Turnover (Average Inventory)	1.52	2.19	2.57	2.74	2.63
Short Term Liquidity
Current Ratio	2.82	3.72	4.15	4	4.17
Quick Ratio	2.32	3.24	3.64	3.6	2.87
Operating Cash Flow to Current Liabilities	0.84	0.24	0.21	0.47	-0.67
Days Sales Outstanding (Average Receivables)	82.64	65.51	59.69	51.89	42.5
Days Outstanding Inventory (Average Inventory)	240.49	166.99	142.11	133.63	138.78
Average Days Payable Outstanding	93.42	90.63	85.62	97.35	100.35
Cash Conversion Cycle (Average Days)	229.72	141.87	116.17	88.17	80.93
Long Term Solvency
Total Debt/Equity	13.61	6.3	3.36	6.37	6.76
Total Debt / Total Capital	11.98	5.93	3.25	5.99	6.34
LT Debt/Equity	-	-	-	-	-
Long-Term Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	27.73	22.6	20.44	21.22	19.83
EBIT / Interest Expense	1.64	5.1	9.63	11.09	8.58
EBITDA / Interest Expense	3.85	7.76	12.1	14.59	11.68
(EBITDA - Capex) / Interest Expense	2.03	7.27	12.1	14.59	5.5
Total Debt / EBITDA	2.98	0.83	0.43	1.05	1.29
Net Debt / EBITDA	-11.07	-8.05	-8.62	-11.85	-9.92
Total Debt / (EBITDA - Capex)	5.66	0.88	0.43	1.05	2.75
Net Debt / (EBITDA - Capex)	-21.04	-8.61	-8.62	-11.85	-21.05
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-19	13.24	2.59	-1.75	-7.14
Gross Profit, 1 Yr. Growth %	-18.48	17.07	3.48	-3.72	-4.3
EBITDA, 1 Yr. Growth %	10.03	75.93	7.92	-14.2	-8.79
EBITA, 1 Yr. Growth %	31.4	171.32	30.83	-18.11	-11.78
EBIT, 1 Yr. Growth %	31.4	171.32	30.83	-18.11	-11.78
Earnings From Cont. Operations, 1 Yr. Growth %	59.13	63.44	34.81	6.41	2.03
Net Income, 1 Yr. Growth %	59.13	63.44	34.81	6.41	2.03
Normalized Net Income, 1 Yr. Growth %	39.26	95.88	29.81	4.3	-4.75
Diluted EPS Before Extra, 1 Yr. Growth %	59.13	64.44	145.95	6.04	2.07
Accounts Receivable, 1 Yr. Growth %	-12.98	-7.07	-5.95	-24.24	-23.08
Inventory, 1 Yr. Growth %	-26.29	-25.77	1.46	-9.79	-7.79
Net Property, Plant and Equip., 1 Yr. Growth %	-1.63	-8.08	-8.2	-7.62	7.7
Total Assets, 1 Yr. Growth %	14.51	-1.69	3.01	11.03	4.03
Tangible Book Value, 1 Yr. Growth %	6.63	5.43	5.88	9.95	5.87
Common Equity, 1 Yr. Growth %	6.63	5.43	5.88	9.95	5.87
Cash From Operations, 1 Yr. Growth %	271.71	-78.36	-13.74	156.81	-240.48
Capital Expenditures, 1 Yr. Growth %	260.61	-76.25	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	56.33	-37.32	-12.94	23.98	-338.17
Unlevered Free Cash Flow, 1 Yr. Growth %	54.81	-36.16	-14.09	21.22	-327.37
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-10.38	-4.23	7.78	0.4	-4.48
Gross Profit, 2 Yr. CAGR %	-9.78	-2.31	10.07	-0.18	-4.01
EBITDA, 2 Yr. CAGR %	-2.54	39.15	37.79	-3.77	-11.53
EBITA, 2 Yr. CAGR %	2.58	88.86	88.41	3.51	-15
EBIT, 2 Yr. CAGR %	2.58	88.86	88.41	3.51	-15
Earnings From Cont. Operations, 2 Yr. CAGR %	30.58	61.28	48.43	19.77	4.2
Net Income, 2 Yr. CAGR %	30.58	61.28	48.43	19.77	4.2
Normalized Net Income, 2 Yr. CAGR %	25.47	65.17	59.46	16.36	-0.33
Diluted EPS Before Extra, 2 Yr. CAGR %	50.69	61.03	101.11	61.5	4.04
Accounts Receivable, 2 Yr. CAGR %	-12.05	-10.07	-6.52	-15.59	-23.66
Inventory, 2 Yr. CAGR %	-18.97	-26.03	-13.22	-4.33	-8.8
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.27	-4.91	-8.14	-7.91	-0.25
Total Assets, 2 Yr. CAGR %	4.87	6.17	0.63	6.95	7.47
Tangible Book Value, 2 Yr. CAGR %	3.23	6.03	5.65	7.89	7.89
Common Equity, 2 Yr. CAGR %	3.23	6.03	5.65	7.89	7.89
Cash From Operations, 2 Yr. CAGR %	331.28	-10.3	-56.79	48.83	89.95
Capital Expenditures, 2 Yr. CAGR %	-	-7.42	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	85.39	-1.02	-26.13	3.9	71.84
Unlevered Free Cash Flow, 2 Yr. CAGR %	111.37	-0.59	-25.94	2.05	66.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-7.89	-3.11	-2.01	4.51	-2.18
Gross Profit, 3 Yr. CAGR %	-8.97	-1.59	-0.41	5.27	-1.57
EBITDA, 3 Yr. CAGR %	-2.44	18.68	27.85	17.66	-5.47
EBITA, 3 Yr. CAGR %	1.02	41.89	67.11	42.72	-1.86
EBIT, 3 Yr. CAGR %	1.02	41.89	67.11	42.72	-1.86
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.45	40.73	51.92	32.84	13.54
Net Income, 3 Yr. CAGR %	-3.45	40.73	51.92	32.84	13.54
Normalized Net Income, 3 Yr. CAGR %	17.46	45.56	52.42	38.42	8.85
Diluted EPS Before Extra, 3 Yr. CAGR %	-3.16	54.67	85.45	62.47	38.59
Accounts Receivable, 3 Yr. CAGR %	-8.3	-10.42	-8.72	-12.84	-18.16
Inventory, 3 Yr. CAGR %	-14.12	-21.3	-17.81	-12.09	-5.5
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.65	-5.56	-6.02	-7.97	-2.98
Total Assets, 3 Yr. CAGR %	1.71	2.68	5.11	3.99	5.97
Tangible Book Value, 3 Yr. CAGR %	2.6	3.96	5.98	7.07	7.22
Common Equity, 3 Yr. CAGR %	2.6	3.96	5.98	7.07	7.22
Cash From Operations, 3 Yr. CAGR %	85.78	59.08	-11.47	-21.73	46
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	91.15
Levered Free Cash Flow, 3 Yr. CAGR %	21.86	29.15	-5.16	-12.21	36.99
Unlevered Free Cash Flow, 3 Yr. CAGR %	20.44	41.82	-5.31	-12.72	33.29
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5.32	-1.8	-1.92	-1.72	-3
Gross Profit, 5 Yr. CAGR %	-3	-1.83	-1.79	-1.03	-1.87
EBITDA, 5 Yr. CAGR %	-5.88	7.45	12.02	9.13	10.34
EBITA, 5 Yr. CAGR %	-3.47	21.69	29.64	25.07	27.52
EBIT, 5 Yr. CAGR %	-3.47	21.69	29.64	25.07	27.52
Earnings From Cont. Operations, 5 Yr. CAGR %	17.02	19.18	14.67	31.94	30.65
Net Income, 5 Yr. CAGR %	17.02	19.18	14.67	31.94	30.65
Normalized Net Income, 5 Yr. CAGR %	10.12	32.39	32.74	33.09	28.61
Diluted EPS Before Extra, 5 Yr. CAGR %	16.68	18.86	29.49	57.36	47.17
Accounts Receivable, 5 Yr. CAGR %	-0.74	-3.85	-7.59	-12.53	-15.02
Inventory, 5 Yr. CAGR %	-10.89	-15.6	-13.76	-14.91	-14.32
Net Property, Plant and Equip., 5 Yr. CAGR %	-6.8	-6.7	-6.66	-6.5	-3.75
Total Assets, 5 Yr. CAGR %	0.69	0.52	1.3	4.36	6.05
Tangible Book Value, 5 Yr. CAGR %	3.1	3.34	3.81	5.51	6.74
Common Equity, 5 Yr. CAGR %	3.1	3.34	3.81	5.51	6.74
Cash From Operations, 5 Yr. CAGR %	30.19	52.29	3.66	54.9	20.15
Capital Expenditures, 5 Yr. CAGR %	127.76	16.99	-	-	43.03
Levered Free Cash Flow, 5 Yr. CAGR %	18.43	32.84	-0.25	18.38	20.29
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.19	25.03	-0.85	24.33	18.54